Jun 22, 2020 / NTS GMT
Christine Corrado - Proactive - Moderator
Hello, and welcome back to proactive New York. I'm Christine Corrado with me right now is Tom Equels CEO at AIM ImmunoTech. Tom, great to see you how are you?
Tom Equels - AIM ImmunoTech Inc. - CEO, President & Executive Vice Chairman
Good to see you again Christine. Looks great, the new hairstyle is wonderful.
Questions and Answers:
Christine Corrado - Proactive - ModeratorThank you very much. Very hot here in New York City, the company has gotten the green light to import Ampligen into Argentina to treat chronic fatigue syndrome. Can you just talk about what kind of work went into actually securing this?
Tom Equels - AIM ImmunoTech Inc. - CEO, President & Executive Vice Chairman
Well, we obtained the first ever. And this is in the work, governmental approval through a well-respected regulatory body, which is Argentina's FDA called ANMAT, commercial approval for Ampligen as a therapy for severe chronic fatigue syndrome.